Individual Treatment of Ustekinumab in Perianal Fistulizing Crohn's Disease

Quantify the Value of Transmural Inflammation in the Treatment of Crohn's Disease With Ustekinumab:an Analysis Based on Imaging Science

NCT05642247 ·Status: COMPLETED

Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease

NCT05387031 ·Status: RECRUITING

Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus Intensified Ustekinumab Therapy in Crohn's Disease

NCT06520397 ·Status: RECRUITING ·Phase: PHASE4

Effectiveness and Safety of Ustekinumab Intensification in Crohn's Disease

NCT05705856 ·Status: UNKNOWN

Ustekinumab and Upadacitinib for Induction and Maintenance Therapy in Patients With Refractory Crohn's Disease: A Multicenter, Randomized, Parallel-Controlled Study

NCT07149467 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease

NCT00265122 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)

NCT01369329 ·Status: COMPLETED ·Phase: PHASE3

Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases

NCT03606499 ·Status: COMPLETED

SIIT Based on UST CDST in Patients With CD

NCT05861167 ·Status: UNKNOWN ·Phase: PHASE4

A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)

NCT07310095 ·Status: RECRUITING ·Phase: PHASE4

An Analysis of the Relationship Between the Genetic Polymorphisms of Interleukin 12 Receptor Subunit Beta 1 and Crohn's Disease in Chinese Patients

NCT07057856 ·Status: COMPLETED

Predictive Factors of Clinical Response to Ustekinumab in Active Crohn's Disease

NCT03351647 ·Status: COMPLETED

De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis

NCT07303686 ·Status: RECRUITING ·Phase: PHASE4

Long-term Treatment With Ustekinumab in Patients With Crohn's Disease and Ulcerative Colitis: a Cohort Study

NCT06802887 ·Status: RECRUITING

Therapeutic Effect of New Biologics in Crohn's Disease

NCT04923100 ·Status: COMPLETED

A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)

NCT01369342 ·Status: COMPLETED ·Phase: PHASE3

A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

NCT04673357 ·Status: COMPLETED ·Phase: PHASE3

An Early Access Program For Ustekinumab In Participants With Moderately To Severely Active Crohn's Disease

NCT03362736 ·Status: NO_LONGER_AVAILABLE

A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis

NCT04372108 ·Status: RECRUITING

USTekinumab in Fistulising Perianal Crohn's Disease (USTAP)

NCT04496063 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab

NCT03167437 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Risankizumab for Fibrostenotic Crohn's Disease Treatment

NCT07177118 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy

NCT00771667 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease

NCT03782376 ·Status: COMPLETED ·Phase: PHASE3

Determination of Ustekinumab Levels in Patients With Crohn's Disease

NCT05057832 ·Status: UNKNOWN